Literature DB >> 7436575

Circulating immune complexes in patients with ankylosing spondylitis.

G S Panayi, J Slaney, B D Williams.   

Abstract

EDTA plasma samples from 13 patients with ankylosing spondylitis (AS) were fractionated on Sephadex G-200 and the quantities of C3 and IgG within the first protein peak determined by a sensitive haemagglutination-inhibition assay. Seven patients with AS had G3 detectable in the first peak and this was associated with an increased concentration of IgG in the corresponding fraction. These 7 patients had more active disease but did not have more peripheral arthritis. Our results indicate that circulating immune complexes capable of initiating complement activation are present in the circulation of patients with ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436575      PMCID: PMC1000582          DOI: 10.1136/ard.39.5.445

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Complement metabolism in the seronegative arthritides.

Authors:  K Whaley; B Canesi; A Moseley; W Morrow; R Sturrock; W Mitchell; W C Dick
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

2.  Correlation between immune complexes and prognostic factors in Hodgkin's disease.

Authors:  P L Amlot; B Pussell; J M Slaney; B D Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

3.  Circulating immune complexes and symptoms in Hodgkin's disease.

Authors:  P L Amlot; J M Slaney; B D Williams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

4.  Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.

Authors:  R J Levinsky; T Lehner
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

5.  Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.

Authors:  A Z Lurhuma; C L Cambiaso; P L Masson; J F Heremans
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

6.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

7.  Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.

Authors:  R W Ebringer; D R Cawdell; P Cowling; A Ebringer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

8.  Detection of immune complexes in serum of patients with ankylosing spondylitis.

Authors:  V Corrigall; G S Panayi; A Unger; R N Poston; B D Williams
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

9.  Immune complexes and complement catabolism in ankylosing spondylitis.

Authors:  R Gabay; R H Zubler; U E Nydegger; P H Lambert
Journal:  Arthritis Rheum       Date:  1977-05
  9 in total
  9 in total

1.  C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.

Authors:  C Huber; A Rüger; M Herrmann; F Krapf; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

3.  Ankylosing spondylitis in North India: a clinical and immunogenetic study.

Authors:  S Prakash; N K Mehra; S Bhargava; M C Vaidya; A N Malaviya
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

4.  Increased incidence of recurrent hematuria in ankylosing spondylitis: a possible association with IgA nephropathy.

Authors:  B A Wall; C A Agudelo; E J Pisko
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

5.  Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes.

Authors:  A J Peeters; A W van den Wall Bake; A D van Dalsen; M L Westedt
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

6.  Membranous glomerulonephritis in a patient with ankylosing spondylitis: a rare association.

Authors:  Ruchika Gupta; Alok Sharma; Raman Arora; Amit K Dinda; Ankur Gupta; Suresh C Tiwari
Journal:  Clin Exp Nephrol       Date:  2009-08-04       Impact factor: 2.801

7.  Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives.

Authors:  O Vinje; P Møller; J Mellbye
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

8.  A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System.

Authors:  V Michael Holers; Francisco G La Rosa; Nirmal K Banda
Journal:  Immune Netw       Date:  2021-12-15       Impact factor: 6.303

9.  Inhibition of Complement Retards Ankylosing Spondylitis Progression.

Authors:  Chaoqun Yang; Peipei Ding; Qingkai Wang; Long Zhang; Xin Zhang; Jianquan Zhao; Enjie Xu; Na Wang; Jianfeng Chen; Guang Yang; Weiguo Hu; Xuhui Zhou
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.